ellacor System with Micro-Coring Technology-Indicated for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV. Model #: Gen 4
FDA Recall Z-2393-2023 · Posted 2023-08-11
Advertisement
Recalling FirmCytrellis Biosystems, Inc.
Recall StatusOpen, Classified
Product CodeQAI
Date Initiated2023-06-23
Product Quantity127 systems
Reason for Recall
Potential failure of a bearing adhesive joint that can occur due to an assembly issue of the X/Y stage of the handpiece. If a broken glue bond were to occur, it could cause an overlap of cores, potentially leading to prolonged healing and irregularities in patient skin texture post-treatment, and/or scarring
Firm Action
Cytrellis Biosystems, Inc issued Urgent Medical Device Recall letter via email on 6/23/23 and revised letter on 7/7/23. Letter states reason for recall, health risk and action to take:
A member of our service engineering team will be reaching out to your practice to schedule a visit to conduct the software update to your console on site. The visit will take approximately 30-45 minutes. Our goal for the completion of updates for all existing customers is by August 31st.
Actions to be taken by the Customer:
1) If you drop or have dropped your handpiece, stop immediate use of the handpiece and contact Cytrellis.
2) Complete the attached Recall Return Response Form and provide it to the service engineering representative that conducts the software update on the device located at your site as acknowledgment of this recall.
Any questions can be directed to [email protected].
Website: www.cytrellis.com
Root Cause
Process control
Distribution Pattern
Nationwide
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement